Real-World Treatment Patterns Among Patients with Type 2 Diabetes Mellitus Initiating Treatment with Oral Semaglutide.

Caroline SwiftMonica S FrazerNoelle N GronroosAndrew SargentMichael LeszkoErin BuysmanSara AlvarezTyler J DunnJosh NooneMico Guevarra

Published in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2024)

This study provides insight for physicians and payers into the real-world prescribing practices within the first 6 months following oral semaglutide initiation and fills the gap in understanding the frequency of regimen changes in the constantly evolving and complex environment of T2DM care.

Keyphrases

primary care
healthcare
type diabetes
quality improvement
cardiovascular risk factors
adverse drug
drug induced